Categories: Insider Trading News

Saba capital administration acquires $7,641 in Pioneer Municipal Excessive Earnings Benefit Fund inventory


Saba Capital Administration, L.P., a major proprietor within the Pioneer Municipal Excessive Earnings Benefit Fund, Inc. (NYSE:MAV), lately elevated its holdings within the firm. Based on a latest SEC submitting, the agency acquired 900 shares of widespread inventory at a value of $8.49 per share on January 21, 2025, amounting to a complete buy worth of $7,641. This transaction brings Saba Capital’s complete shares owned within the fund to three,909,084. The fund, at the moment valued at $203.75 million, maintains a robust monetary place with a present ratio of 17.9 and has constantly paid dividends for 23 consecutive years, in line with InvestingPro knowledge. The acquisition displays ongoing curiosity within the fund by Saba Capital, which is led by Boaz Weinstein, a notable determine within the monetary sector. Buying and selling at a P/E ratio of 5.09 and demonstrating low value volatility, MAV exhibits promising metrics. For deeper insights and extra evaluation, buyers can entry extra unique recommendations on InvestingPro.

This text was generated with the assist of AI and reviewed by an editor. For extra info see our T&C.

admin

Share
Published by
admin

Recent Posts

Zscaler’s SWOT evaluation: cloud safety inventory poised for development amid challenges

Zscaler (NASDAQ:ZS), a number one supplier of cloud-based safety options valued at $29.63 billion, has…

9 minutes ago

Trump insurance policies prone to increase bond market’s inflation fears, prime cash managers say

By Davide Barbuscia NEW YORK (Reuters) - Large U.S. asset managers overseeing nicely over $20…

24 minutes ago

Givaudan tops 2024 forecasts with robust gross sales progress throughout markets

(Reuters) -Swiss perfume and flavour maker Givaudan on Friday reported annual outcomes above market expectations,…

39 minutes ago

German enterprise exercise stabilises in January, PMI reveals

By Maria Martinez BERLIN (Reuters) - Enterprise exercise in Germany's non-public sector stabilised in January,…

44 minutes ago

Cosmos well being CEO Grigorios Siokas acquires shares price $29,999

The acquisition is a part of a debt alternate settlement between Mr. Siokas and Cosmos…

54 minutes ago

Inhibrx’s SWOT evaluation: oncology biotech inventory faces pivotal 12 months forward

Inhibrx Biosciences , Inc. (NASDAQ:INBX), a clinical-stage biopharmaceutical firm valued at $205.41 million, is navigating…

1 hour ago